Study design: Investigation of ®ve patients receiving an implant, using laboratory cystometry and self-catheterisation at home. Objectives: To use the established Finetech-Brindley sacral root stimulator to increase bladder capacity by neuromodulation, eliminating the need for posterior rhizotomy, as well as achieving bladder emptying by neurostimulation. Setting: Spinal Injuries Unit, Royal National Orthopaedic Hospital, Stanmore, Middlesex, UK. Methods: Five patients underwent implantation of a Finetech-Brindley stimulator without rhizotomy of the posterior roots. This was either a two channel extradural device (four cases) or a three channel intrathecal device (one case). In each patient, the implant was con®gured as a Sacral Posterior and Anterior Root Stimulator (SPARS). Postoperatively, repeated provocations using rapid instillation of 60 ml saline were used to determine the relative thresholds for neuromodulation using each channel. The eect of continuous neuromodulation was examined in the laboratory using slow ®ll cystometrograms, and conditional stimulation was also studied (neuromodulation for 1 min to suppress hyperre¯exic contractions as they occurred). In one patient, neuromodulation was applied continuously at home, and volumes at self catheterisation recorded in a diary. Results: Re¯ex erections were preserved in each patient. In three patients, detrusor hyperre¯exia persisted postoperatively and neuromodulation via the implant was studied. In these three patients, the con®guration was: S2 mixed roots bilaterally (channel B), and S34 bilaterally (channel A). Both channels could be used to suppress provoked hyperre¯exic contractions, with the S2 channel eective at a shorter pulse width than S34 in a majority of cases. Continuous stimulation more than doubled bladder capacity in two out of three patients during slow ®ll cystometry. Conditional stimulation was highly eective. In the one patient who used continuous stimulation at home, bladder capacity was more than doubled and the eect was comparable with anticholinergic medication. Bladder pressures 470 cm water could be achieved with intense stimulation in three patients, but detrusor-external urethral sphincter dyssynergia (DSD) prevented complete emptying. Conclusions: Neuromodulation via a SPARS was eective and may replace the need for posterior rhizotomy. However, persisting DSD may prevent complete bladder emptying and warrants further investigation.
Introduction
It has been known for some time that stimulation of the pudendal aerents or sacral nerve roots suppresses bladder activity. This eect is observed in normal subjects, 1 idiopathic bladder instability, 2 and in the detrusor hyperre¯exia that is the likely consequence of spinal cord injury. 3 It can be termed neuromodulation, where`the in¯uence of activity in one neural pathway aects the pre-existing activity in another by synaptic interaction.
Untreated detrusor hyperre¯exia may cause incontinence ± and when it occurs with detrusor-external sphincter dyssynergia, high bladder pressures and, if untreated, vesicoureteric re¯ux leading to renal impairment. Preventing this sequence of events is a primary aim of bladder management in those with spinal cord injury.
Initial experiments with anal stimulation 5 and penile squeeze 6 demonstrated bladder suppression in SCI patients, and over the last 20 years four centres have shown that skin stimulation of the Dorsal Penile Nerve can reliably increase bladder capacity.
3,7 ± 9 Stimulation of the sacral roots, whether magnetically 10 or by percutaneous 11 or implanted electrode, 12 is probably at least as eective. However, although there is now a large quantity of data about the short term eects of neuromodulation, it has been more dicult to apply it in the long term. Two groups have shown that application of sacral root stimulation via implanted electrodes can increase capacity to a functionally useful degree, 12, 13 but the situation in spinal cord injury lags behind the treatment of the urinary urge group, where the Medtronic Interstim is an accepted and eective implant. 2 The Finetech-Brindley Sacral Anterior Root Stimulator (SARS or Vocare, Neurocontrol, USA) is an established and successful device for bladder and bowel emptying in Spinal Cord Injury, and is usually accompanied by a rhizotomy of the posterior (sensory) sacral roots. Although the early SARS devices were often implanted without rhizotomy, the procedure became standard as its great bene®ts were realised: a low pressure, high capacity bladder and elimination of active detrusor-external urethral sphincter dyssynergia.
14 However, rhizotomy is unacceptable to many patients because it abolishes re¯ex erection and ejaculation, and is destructive ± the latter becoming an increasingly important factor as the prospects for spinal cord regeneration improve. It may also cause sphincter and pelvic¯oor weakness, and in a minority of patients, stress incontinence. 15 Without rhizotomy, a SARS device has the potential to be used for neuromodulation to increase bladder capacity, and neurostimulation for bladder and bowel emptying. It is then a Sacral Posterior and Anterior Root Stimulator ± SPARS. Because the eects of neuromodulation are mediated by myelinated A aerent ®bres, 16 it can be achieved by low-level stimulation of the mixed sacral roots, with more intense stimulation to activate preganglionic eerent B ®bres to empty the bladder and bowel when required. Use of an extradural device to stimulate the mixed nerves is simpler and probably safer than intradural separation into anterior and posterior roots.
The aim of this study was to establish the ecacy of both acute and chronic neuromodulation via a FinetechBrindley stimulator in SPARS con®guration. We describe three patients in which neuromodulation and bladder stimulation have been achieved with this device.
Materials and Methods
Local ethics committee approval and informed consent were obtained. Five patients were implanted with SPARS devices. All had detrusor hyperre¯exia (as de®ned by International Continence Society 17 ) preoperatively, but in two patients this was not present postoperatively. The patients are listed in Table 1 .
Cystometry
Anticholinergic medication was stopped at least 4 days before cystometry. In all tests, a ®lling rate of 10 ml/min was used. This was chosen to be as close as possible to natural ®lling while allowing a sucient number of cystometrograms to be performed on one day. Filling was stopped when there was a sustained rise in bladder pressure of 435 cm water, or incontinence ±`®ring o'. Bladder capacity was calculated by adding the volume ®red o to the residual measured by aspiration. Two types of urethral catheter were used: either standard urodynamics catheters (10 French ®lling and small bore pressure catheter) or a four channel microtip pressure transducer (Gaeltech, Isle of Skye, UK). The latter has three urethral and one bladder pressure transducer; between them is an asymmetric balloon which, with gentle pulling, lodges in the bladder neck. The position of the catheter was con®rmed by observing rapid, large pressure rises with SPARS stimulation at the urethral transducers, characteristic of external urethral sphincter contraction. All tests were conducted in the supine position.
Preoperative tests
In each patient, two control cystometrograms were performed to establish baseline bladder capacity. The The parameters used were derived from previous work at our institution using provoked contractions. 18 Bladder capacity with continuous stimulation was measured during three ®lls with neuromodulation. If possible, a ®nal control ®ll was performed to assess the residual eects of neuromodulation.
Implantation
In four patients (AS, GD, DL, PG), a laminectomy from L 5 to S 2 was performed. Standard Finetech-Brindley extradural electrodes (Neurocontrol, Cleveland, USA) were placed bilaterally on the mixed S 2 roots (channel B) and bilaterally on the mixed S 3 and S 4 roots (channel A). In one patient (SN), a three channel intrathecal implant was used, with electrodes placed bilaterally on S3 anterior roots (channel A), S3 posterior roots (channel B) and S4 mixed roots (channel C).
Postoperative tests
Postoperative cystometry was used to con®rm hyperreexia and record baseline bladder capacity. The eects of sacral root stimulation were then examined in detail, as follows:
Provocations Repeated rapid instillations of 60 ml Normal Saline over 5 ± 10 s at room temperature were used to provoke hyperre¯exic contractions. Provocation was deemed successful if detrusor pressure rose by 15 cm water or more. In almost all cases such a pressure rise indicated the start of a hyperre¯exic contraction. If the provocation was not successful, a further 60 ml was instilled. Control and neuromodulation provocations were interleaved, and stimulation was always conditional ± applied only once the bladder pressure rise of 15 cm water had occurred. At the end of each provocation test, 60 ml was aspirated from the bladder.
As in the tests with Dorsal Penile Nerve stimulation, frequency was set at 15 Hz. The FinetechBrindley device allows only large variations in the intensity of stimulation, and for neuromodulation this was always set at 1 (the lowest available). The pulse width was varied from 8 to 256 ms to determine the threshold value for successful neuromodulation. This also allowed determination of thresholds for urethral and anal sphincter contraction.
Slow ®lls After two control cystometrograms, bladder capacity was measured with continuous stimulation via the SPARS. The pulse width was set at between 1.5 and 5 times the threshold level determined using provoked contractions for both channels. This was always several times less than the level necessary to produce a bladder contraction. In addition, in one patient alternating ®lls were performed using the S2 and S34 channels to con®rm the ecacy of neuromodulation with each.
In two patients, the eects of conditional neuromodulation were studied. Here, stimulation was applied for 1 min at the start of a hyperre¯exic contraction 9 ± de®ned as a rise in intravesical pressure of greater than 10 cm water. If the contraction was not completely suppressed after 1 min, stimulation was continued for a further minute. These parameters were derived from previous work on conditional neuromodulation via the dorsal penile nerve. 9 The criteria for ending ®lling were the same as during continuous ®lls.
Long term neuromodulation In one patient, the transmitter of the Finetech-Brindley device was ®xed to the skin using a variety of stoma management materials, and continuous stimulation applied at between three and six times the threshold for suppression of provoked contractions. Two identically programmed transmitter boxes were used alternately, to allow charging. Bladder capacity was measured by self catheterisation, and where incontinence occurred before catheterisation, an attempt was made to estimate its volume. A program of 50 s on, 50 s o stimulation was tried and comparison periods with no stimulation and with oxybutinin were included.
Bladder emptying Conventional interval voiding programs were tried in each patient, and optimised using videourodynamics and the multitip urethral pressure transducer.
Erectile function Patients completed a questionnaire of erectile function before and after the implant. Because re¯ex erections in spinal cord injury are often variable, we considered this more accurate than testing erectile function in the laboratory.
Criteria for measurement and data analysis
In the preoperative and postoperative tests using slow ®lling, bladder volume at ®ring o or sustained detrusor pressure rise 435 cm water was recorded for each ®ll.
In the postoperative experiments using provoked contractions, the primary measure was the threshold pulse width for successful neuromodulation using each channel. This was derived by plotting the area under 60 s of the bladder pressure-time trace for each provocation, with the data ®tted where possible to a Boltzmann sigmoid curve. If the ®t was not possible, a best-®t line was drawn manually. The threshold for neuromodulation was de®ned as the pulse width which gave 50% of maximum suppression. For each patient, the provocation tests were repeated on a separate day and the mean of the two thresholds calculated (a total of 6 days' testing).
In the home experiments, bladder volume at self catheterisation was the primary measure. Results were compared using a two-tailed Mann-Whitney U test with a signi®cance level of 95%.
Results
Preoperative neuromodulation with dorsal penile nerve stimulation This resulted in at least a 70% increase in bladder capacity in four patients (GD, DL, SN, PG). In AS, detrusor hyperre¯exia occurred at a bladder volume of 400 ± 500 ml, so that continuous neuromodulation was not tried; previous experiments had demonstrated suppression of provoked hyperre¯exic contractions with dorsal penile nerve stimulation. The results are shown in Figure 1 . Volume increased progressively with each neuromodulation ®ll.
Postoperative ®ndings
In all ®ve patients, re¯ex erections were preserved. In four patients, they were`no dierent' compared to preoperatively, and in AS (who had other evidence of damage to the posterior roots) they were still present but less frequent than before implantation.
In two patients (AS and SN), detrusor hyperre¯exia was present preoperatively but was not reproducible postoperatively either during slow ®lling or on provocation with rapid instillation of saline. In both cases, changes in the threshold for the DPN re¯ex and skeletal muscle and bladder responses to stimulation suggested partial sacral root damage. These patients will not be described in the sections on postoperative neuromodulation that follow.
Postoperative tests using provoked contractions In each of the three patients, it was possible to determine thresholds for suppression of provoked contractions using each channel of the stimulator. A sample series of provocations (with controls) is shown in Figure 2 , and the method for calculation in Figure 3 .
There was considerable variation between days 1 and 2 in the calculated thresholds for neuromodulation ( Table  2 ). In four out of six tests, the threshold pulse width for suppression of provoked contractions was lower with the S2 channel, and the mean threshold for the 2 days testing was lower with S2 in two out of three patients.
The threshold for neuromodulation was also expressed as a multiple of the threshold for urethral or anal sphincter contraction. adjusted in this way, the mean S2 threshold is lower than the mean S34 threshold in each patient (Table 2 ). Anal and urethral sphincter pressure rises at the threshold for neuromodulation were not consistently higher with S2 or S34.
The degree of skeletal muscle contraction at the threshold for neuromodulation using each channel is shown in Table 3 .
Slow ®ll cystometry with neuromodulation
In each patient, neuromodulation increased bladder capacity. DL has high pressure detrusor hyperre¯ex-ia, and neuromodulation on three occasions has increased his capacity by no more than 35%. Results in PG and GD are better (Figure 4 ). Conditional Figures 5, 6 ).
Long term neuromodulation
In one subject (PG), neuromodulation was used intermittently at home for a period of 4 months. The volumes at self-catheterisation are shown in Figure 7 . The patient found it dicult to wear a sheath, and used an indwelling catheter when urine output was likely to be high or catheterisation inconvenient. This also made accurate estimation of the volume ®red o dicult.
The median volume at self-catheterisation (excluding volume ®red o) was 100 ml in the control period, and 250 ml in the continuous, on/o and oxybutinin periods. The dierence between control and all other periods was highly signi®cant (P50.0001) in each case. There was not a signi®cant dierence between continuous, on/o and oxybutinin periods.
Bladder emptying
In one patient (AS), complete bladder emptying was achieved with intense intermittent stimulation of the S34 channel. However, this patient had mild detrusor hyperre¯exia and little evidence of detrusor-sphincter Figure 3 Example showing the calculation of threshold for neuromodulation in one patient. For each patient, data similar to this was collected on two separate days Figure 8 .
In one patient (GD) it is not yet possible to achieve signi®cant detrusor pressure with stimulation, in spite of intact hyperre¯exia and good bladder pressure rises during intraoperative stimulation. The failure to produce a bladder contraction is probably due to a combination of electrode malposition and neuropraxia.
Discussion
At the start of this study, we tested the response to Dorsal Penile Nerve stimulation to ensure that patients responded to neuromodulation before embarking on a SPARS implant. In our experience, bladder capacity almost always increases 9 with this method of neuromodulation if the intensity of stimulation is set at an optimum level. Testing neuromodulation by percutaneous sacral nerve stimulation (in a similar way to the Peripheral Nerve Evaluation (PNE) test used before implantation of the Medtronic Interstim 11 ) is more invasive and in this case may not necessarily be more informative: if a patient responds to dorsal penile nerve stimulation, it is reasonable to suppose that the same aerent ®bres can be activated by an implant capable of stimulating sacral roots 2 to 4.
In the four patients tested, dorsal penile nerve stimulation markedly increased bladder capacity. The results of laboratory tests are probably best in patients with signi®cant hyperre¯exia who have good bladder capacities with anticholinergics: the capacity falls rapidly on stopping this medication, and is restored with neuromodulation. For this reason, the results with acute neuromodulation using dierent techniques should be compared with caution: the improvement in bladder capacity is highly dependent on the patient group.
This variability means that any attempt to compare the ecacy of neuromodulation via dierent sacral roots should either involve large numbers of patients, or a method where dierent roots may be stimulated in the same patient. Although our series consisted of only three patients, it presented a valuable opportunity for the latter. Provocation of unstable contractions is quick and reproducible, allowing the evaluation of a large number of parameter changes during 1 day of testing.
The stimulation program in the Finetech-Brindley control box allows ®ne variation in pulse width rather than amplitude. At the settings used here, charge delivered is proportional to pulse width and therefore approximates to intensity, but is not exactly equivalent. 19 Consistent with previous ®ndings, 10,20 detrusor hyperre¯exia could be reliably provoked many times in each patient, with a gap of only 3 min between episodes of neuromodulation. That the residual eect of neuromodulation after several minutes was not sucient to prevent a hyperre¯exic contraction contrasts with the persistent eects seen during Figure 4 Bladder capacity with short-term continuous neuromodulation via SPARS Figure 5 Sample cystometrogram trace in PG during conditional neuromodulation. The bladder was ®lled from empty at 10 ml/min Figure 6 The eect of various parameter changes on the bladder capacity achieved with neuromodulation Figure 7 Bladder volume at self-catheterisation: serial measurements during the ®ve marked periods in PG Suppression of detrusor hyperreflexia with a Fintech-Brindley stimulator APS Kirkham et al repeated slow ®lls with continuous neuromodulation, where the eects on bladder volume at ®rst contraction seem to persist for several hours. 9 The likely explanation is that the inhibition of the detrusor re¯ex gradually diminishes: after 3 min it can be overcome by an intense stimulus (such as the provocation described in this study), but a smaller inhibition can in¯uence the threshold for detrusor hyperre¯exia during slow bladder ®lling. The aim of interleaving of provocations with and without neuromodulation during this study was to minimise the in¯uence of such carry over eects. In all three patients, we found that the area under the detrusor pressure curve for control provocations was not markedly aected by preceding neuromodulation.
Although the results of each day's testing allowed calculation of threshold pulse widths, agreement between the 2 days was poor in DL and only fair in PG. DL has never had marked increases in bladder capacity with neuromodulation, implying that the eect of sacral root stimulation is weak in him, and this may be re¯ected in the variability of the results with provocation. In PG and GD, S2 stimulation produced neuromodulation at a lower (three out of four tests) or similar (one test) threshold compared to S34, and normalisation of the neuromodulation threshold to the threshold for anal and urethral sphincter contraction did not markedly aect the ®ndings. In GD, however, where the dierence is largest, there is certainly a degree of neuropraxia of the S34 roots, because bladder contractions cannot be achieved. It is therefore likely that there is some neuropraxia of the S34 ®bres responsible for neuromodulation, which may account for some of the dierence between S2 and S34.
Schmidt has asserted that`The key to control of the bladder lies in control of the sphincter, 21 and has also observed that stimulation of S2 gives larger external urethral sphincter contractions than S3 or S4, 22 which is consistent with our ®nding that S2 was in most cases eective at a lower pulse width than S34. However, there is not agreement on this point, and others have found that S3 has the largest contribution. 23 Also, there are several pieces of evidence suggesting that although sphincter contraction may be a marker for an adequate stimulus for neuromodulation, it is not central to the mechanism. Firstly, skeletal muscle paralysis does not abolish bladder suppression in cats, 24 and secondly, stimulation of aerent branches of the pudendal nerve that innervate the region of the external urethral sphincter does not suppress bladder activity in cats, whereas stimulation of aerents from the penis does. 25 Although our ®nding of a generally lower threshold for S2 may be due to several causes (some of them artefactual), we have shown that this root certainly can be used for neuromodulation. It is likely that S3 was chosen for the Interstim device Figure 8 Two examples of intermittent voiding programs for bladder emptying (SN and DL). In each case, detrusor-external urethral sphincter dyssynergia can be seen in the gaps between stimulation (and for previous trials of long-term stimulation in spinal cord injury) because it produces less skeletal muscle contraction than S2. 21 It may be that in neurologically intact patients this does make S3 or S4 preferable, but none of our SCI patients experienced inconvenient skeletal muscle contractions with either S2 or S34 stimulation. Also, one might expect chronic stimulation of the glutei to have a bene®cial eect on muscle bulk.
We found that neuromodulation via the SPARS during slow ®lling can markedly increase bladder capacity: in two patients bladder capacity was more than doubled, and in one it increased by a third. The results were not analyzed statistically because the number of patients was small, bladder capacity is probably not normally distributed and the`carry over' eect from previous stimulations is considerable.
To study the eect of conditional stimulation, the ®lling rate should be low (50 ml/min is probably too provocative) and it must be possible to turn the stimulation on and o rapidly. These conditions have not been present in previous studies of sacral root neuromodulation. 11, 12 We used conditional stimulation in the two patients who responded well to continuous stimulation, and found it to be highly eective, consistent with a previous ®nding that conditional stimulation via the dorsal penile nerve is probably at least as eective as continuous. 9 It suggests that current research to develop a device for conditional neuromodulation ± capable of detecting bladder pressure rises by recording from the sacral roots, and then suppressing them by stimulation ± is justi®ed. The trigger of 10 cm water chosen in this study is similar to the smallest rises in bladder pressure that can be detected by recording from the cat sacral roots. 26 In previous studies with implanted stimulators for long-term neuromodulation in SCI 12, 13 cystometry was performed at prede®ned intervals after implantation to assess the eect of neuromodulation. Especially with the ®lling rates used (50 ml/min or greater), this does not necessarily re¯ect the bladder capacity that the patient experiences at home. It was also not applicable in our case, as the patient used stimulation for variable periods of 4 days to 2 weeks.
Instead, volume at self catheterisation was our primary outcome variable. Recording the volume leaked with a pad and adding this to catheterised volume would have increased the complexity of the measurements and is not necessarily informative: if the patient does not self catheterise immediately after ®ring o', bladder capacity will be overestimated. We considered it more reliable (and easier for the patient) to record bladder volumes at self catheterisation for a long period, and to infer the bladder capacity from the maximum volumes achieved without incontinence. Measuring frequency of self-catheterisation is unreliable as the decision to catheterise is a subjective one, and patients may alter their¯uid intake according to their bladder management.
Our current method for long term stimulation is not ideal: it is necessary to ®x the transmitter coils to the skin over the subcutaneous receiver for all but the ®rst 30 ± 60 min after bladder emptying. However, PG used the device intermittently at home over a period of 4 months, and the results show a marked increase in bladder capacity. When stimulation is stopped, this returns in less than 1 day to a much smaller baseline capacity. The eect of neuromodulation was comparable with oxybutinin, although PG stated that incontinence on ®lling past bladder capacity is generally of larger volume with neuromodulation ± when the bladder`escapes' from electrical suppression, it contracts at close to full force. We did not ®nd that the eect of neuromodulation diminished with time, or that there was a need to increase the stimulation parameters. However, as shown in Figure 8 , some incontinence persisted (although stress incontinence was improved with neuromodulation, probably because of persistent urethral sphincter contraction). Volumes with the 50 s on/50 s o program were no worse than with the continuous pattern, and indeed the patient felt strongly that this pattern was more eective than continuous stimulation. He preferred neuromodulation to oxybutinin.
The diculty in achieving good bladder emptying using the established interval voiding technique is likely to be due to detrusor-external urethral sphincter dyssynergia in DL and SN, and in addition pelvic¯oor and periurethral muscle spasm in PG. In each case, intact sacral posterior root pathways are likely to be a signi®cant factor. As Brindley suggested, 27 bladder emptying would probably be improved by posterior rhizotomy, and we would not currently implant a SPARS device without rhizotomy in patients with severe detrusor-external sphincter dyssynergia. Brindley's early patients often did not have a rhizotomy, and most achieved good emptying, but the devices were intrathecal and there was posterior root damage in many cases. 28 We are currently investigating dierent strategies to improve bladder emptying in the patients described here.
In summary, stimulation of the Dorsal Penile Nerve is a simple and non-invasive screening test for the bladder response to neuromodulation. As well as stimulation for bladder emptying, the FinetechBrindley device can be used to suppress provoked contractions and markedly increase bladder capacity in the laboratory, and we have shown that it is feasible to use long-term stimulation at home as a replacement for oxybutinin. Conditional neuromodulation of the sacral roots was highly eective and is a promising technique for future implanted devices.
